Gall bladder ailments have risen significantly in recent times due to faulty dietary patterns and at risk genes. Market Research Future, a firm which specializes in market reports related to the healthcare sector among others, recently published a report on this market. The industry for gallstone treatment is expected to grow at a CAGR rate of 6.5% and is estimated to reach USD 27121.5 million in revenue by 2023.
The market size has increased substantially due the increase in the number of cases related to gall bladder. This trend has subsequently set off the development of various treatment options for the ailment causing the industry to expand further on a global scale. Escalating level of interest in terms of R & D and investment from investors in the healthcare and other ancillary sectors has further prompted the rapid development of this sector.
Get a sample report at https://www.marketresearchfuture.com/sample_request/3945 .
The market for gall bladder treatment has been categorized on the basis of diagnosis, disease indications, treatment and end users. On the basis of disease indications the industry is segmented as gallstones, cholecystitis & biliary colic, cholelithiasis & choledocholithiasis, gallbladder polyps, gall bladder cancer. Furthermore, on the basis of diagnosis the market is divided into ultrasound, blood tests, computerized tomography (CT), cholangiography and hepatobiliary scintigraphy among others. The category on treatment basis is segmented into surgery and drugs and lastly on the basis of end users the industry is divided into hospitals & gynecology clinics, academic & research centers and others.
Detailed Regional Analysis
Taking into account the worldwide scenario of the market, the North American market dominates the gall bladder treatment market worldwide due to the presence of a huge population suffering from gall bladder diseases. US is the largest market share holder in the North American gall bladder treatment market. In developed countries, about 10–15% of adults have developed gallstones and other related diseases. The European market follows as the second largest market for the gall bladder treatment which is followed by Asia Pacific. Due to the existence of a well-developed healthcare sector and high healthcare expenses, the gall bladder treatment market in Europe is growing at a CAGR of 6.8%. The Asia Pacific region is also witnessing fast growth in this market which is mainly due to rapidly escalating awareness of treatments, presence of huge population, growing healthcare expenditure and government support for research & development. The Asia Pacific gall bladder treatment market is anticipated to grow at a CAGR of 7.0% during the forecasted period. The Middle East & Africa region is however expected to demonstrate limited growth.
Browse Complete Report at https://www.marketresearchfuture.com/reports/gallbladder-treatment-market-3945 .
Global Competitive Analysis
Companies are transforming the sector in a major way which has led to an accelerated the growth pace of the sector. The industry players in the segment are utilizing their primary resources to initiate a trend of solid, volume-driven growth that has been observed in the market with the development of different varieties of product types. The firms are also aiming to capture a substantial share of the market segment as early as possible byexperimenting with various advantage points.The best long-term growth opportunities for this sector can be harnessed by ensuring ongoing process improvements and maintaining financial fluidity to invest in the optimal strategies.The key players of this market are Intuitive Surgical, Dornier MedTech, Boston Scientific Corporation, C. R. Bard, Inc., B. Braun Melsungen AG, Koninklijke Philips N.V., Sanofi and among other prominent industry players.
Latest Industry News:
Oct 2017 Research has identified a protein that drives tumor growth and has subsequently opened up a new therapeutic target for gallbladder cancer research studies. The study was carried out in association with Johannes Haybaeck of the University of Magdeburg, who has built the world’s biggest collection of gallbladder cancer tissue samples. According to the research, large amounts of IMP2 in cells cause tumors to grow faster.
Dec 2017 According to a study conducted by Dr Ryan Howard, his team found that far fewer opioid painkillers are needed than previously thought for people who have their gallbladder removed. The group analyzed information from 170 patients who had their gallbladder removal surgery at Michigan Medicine, the university’s medical center. The researchers found that the average patient received a prescription of 250 milligrams of opioid painkillers (about 50 pills) after their operation based on which the researchers developed a much lower opioid prescribing guideline along with a new patient education program related to pain control.
More Inquire at https://www.marketresearchfuture.com/enquiry/3945 .
The report for Global Gall Bladder Treatment Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions
Company Name: Market Research Future
Contact Person: Akash Anand
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –